To further confirm the role of PIK3R2 and MADD in miR-3151-mediated tumor suppression in CLL cells, knockdown of each of PIK3R2 and MADD was performed in WAC3CD5+ cells with complete miR-3151 methylation. The gene discussed is MADD; the disease is B-cell chronic lymphocytic leukemia.